4.5 Article

Type I interferons suppress CD4+ T-cell-dependent parasite control during blood-stage Plasmodium infection

期刊

EUROPEAN JOURNAL OF IMMUNOLOGY
卷 41, 期 9, 页码 2688-2698

出版社

WILEY
DOI: 10.1002/eji.201141539

关键词

Cytokines; Immune regulation; Interferons; Malaria; T helper cells

资金

  1. Australian National Health and Medical Research Council [613702, 496600]
  2. Australian Centre for Vaccine Development

向作者/读者索取更多资源

During blood-stage Plasmodium infection, large-scale invasion of RBCs often occurs before the generation of cellular immune responses. In Plasmodium berghei ANKA (PbA)-infected C57BL/6 mice, CD4(+) T cells controlled parasite numbers poorly, instead providing early help to pathogenic CD8(+) T cells. Expression analysis revealed that the transcriptional signature of CD4(+) T cells from PbA-infected mice was dominated by type I IFN (IFN-I) and IFN-gamma-signalling pathway-related genes. A role for IFN-I during blood-stage Plasmodium infection had yet to be established. Here, we observed IFN-alpha protein production in the spleen of PbA-infected C57BL/6 mice over the first 2 days of infection. Mice deficient in IFN-I signalling had reduced parasite burdens, and displayed none of the fatal neurological symptoms associated with PbA infection. IFN-I substantially inhibited CD4(+) T-bet 1 T-cell-derived IFN-gamma production, and prevented this emerging Th1 response from controlling parasites. Experiments using BM chimeric mice revealed that IFN-I signalled predominantly via radio-sensitive, haematopoietic cells, but did not suppress CD4(+) T cells via direct signalling to this cell type. Finally, we found that IFN-I suppressed IFN-gamma production, and hampered efficient control of parasitaemia in mice infected with non-lethal Plasmodium chabaudi. Thus, we have elucidated a novel regulatory pathway in primary blood-stage Plasmodium infection that suppresses CD4(+) T-cell-mediated parasite control.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Dermatology

BRN2 and MITF together impact AXL expression in melanoma

Jacinta L. Simmons, Hannah M. Neuendorf, Glen M. Boyle

Summary: The inverse relationship between the transcription factor MITF and the receptor tyrosine kinase AXL has been found to play a role in therapy resistance in melanoma tumors. A population of cells within melanoma tumors with extremely high expression of AXL and negative/low expression of both MITF and the transcription factor BRN2 was identified. Depletion of both transcription factors from melanoma cell lines led to an increase in AXL expression, and re-expression of BRN2 resulted in decreased AXL expression, suggesting a role for BRN2 in regulating AXL levels independently of MITF.

EXPERIMENTAL DERMATOLOGY (2022)

Article Hematology

Donor bone marrow-derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice

Rachael C. Adams, Dylan Carter-Cusack, Samreen N. Shaikh, Genesis T. Llanes, Rebecca L. Johnston, Gregory Quaife-Ryan, Glen Boyle, Lambros T. Koufariotis, Andreas Moller, Bruce R. Blazar, Jana Vukovic, Kelli P. A. MacDonald

Summary: This study reveals the development mechanism of chronic GVHD in the CNS after stem cell transplantation, including neuroinflammation and abnormal gene expression. The study found that donor-derived macrophages play an important role in CNS cGVHD.
Article Dermatology

Reciprocal Regulation of BRN2 and NOTCH1/2 Signaling Synergistically Drives Melanoma Cell Migration and Invasion

Mitchell E. Fane, Yash Chhabra, Loredana Spoerri, Jacinta L. Simmons, Raquelle Ludwig, Elise Bonvin, Colin R. Goding, Richard A. Sturm, Glen M. Boyle, Nikolas K. Haass, Michael Piper, Aaron G. Smith

Summary: A reciprocal relationship between BRN2 and NOTCH1/2 signaling exists in melanoma cells, bolstering acquisition of invasiveness. Working through the epigenetic modulator EZH2, the BRN2-NOTCH1/2 axis is potentially a key mechanism by which the invasive phenotype is maintained.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Editorial Material Cell Biology

Publication speed: a balancing act between author urgency and editorial process

Jessica G. Borger, Ashraful Haque

IMMUNOLOGY AND CELL BIOLOGY (2023)

Article Obstetrics & Gynecology

Quality of oxytocin and tranexamic acid for the prevention and treatment of postpartum hemorrhage in Kenya, Nigeria, South Africa, and Tanzania

Anne Ammerdorffer, Sara Rushwan, Rebecca Timms, Philip Wright, Leanne Beeson, Adam J. Devall, Kristie-Marie Mammoliti, Fadhlun M. Alwy Al-Beity, Hadiza Galadanci, G. Justus Hofmeyr, Mandisa Singata-Madliki, Zahida Qureshi, Pete Lambert, Ioannis D. Gallos, Arri Coomarasamy, A. Metin Guelmezoglu

Summary: The study aimed to assess the quality of oxytocin and tranexamic acid products for prevention and treatment of postpartum hemorrhage. While most tranexamic acid samples had adequate content, a concerning number of oxytocin samples were found to be substandard, indicating a need for further investigation.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2022)

Article Plant Sciences

Cryptic Epoxytiglianes from the Kernels of the Blushwood Tree (Fontainea picrosperma)

Giuseppina Chianese, Hawraz Ibrahim M. Amin, Chiara Maioli, Paul Reddell, Peter Parsons, Jason Cullen, Jenny Johns, Herlina Handoko, Glen Boyle, Giovanni Appendino, Orazio Taglialatela-Scafati, Simone Gaeta

Summary: The kernels of the Australian blushwood tree contain a high concentration of phorboids, which can be used to produce the anticancer drug tigilanol tiglate. Unlike croton oil, the oily matrix of the blushwood kernels mainly consists of free fatty acids. By active partitioning, a hidden tigliane fraction was recovered and characterized for the first time. The esterification profile of the epoxytigliane di- and triesters differs, and certain esters showed cytotoxic activity.

JOURNAL OF NATURAL PRODUCTS (2022)

Review Oncology

Heterogeneity in Melanoma

Mei Fong Ng, Jacinta L. Simmons, Glen M. Boyle

Summary: Tumour heterogeneity is a phenomenon in which cancer cells evolve diversely during the course of the disease, impacting the evolution and resistance to therapy of the tumour. As one of the most heterogeneous human cancers, melanoma plays an important role in disease progression and treatment response.

CANCERS (2022)

Article Cell Biology

Topical, immunomodulatory epoxy-tiglianes induce biofilm disruption and healing in acute and chronic skin wounds

Lydia C. Powell, Jason K. Cullen, Glen M. Boyle, Tom De Ridder, Pei-Yi Yap, Wenya Xue, Carly J. Pierce, Manon F. Pritchard, Georgina E. Menzies, Muthanna Abdulkarim, Jennifer Y. M. Adams, Joana Stokniene, Lewis W. Francis, Mark Gumbleton, Jenny Johns, Katja E. Hill, Adam V. Jones, Peter G. Parsons, Paul Reddell, David W. Thomas

Summary: This study reports a non-antibiotic approach using naturally occurring and semisynthetic compounds to treat chronic skin wounds by modifying bacterial growth and inducing biofilm disruption. The compounds were found to stimulate immune responses and exhibit antimicrobial activity, leading to the resolution of infection and wound healing.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Biochemistry & Molecular Biology

Anti-Fibrotic Potential of Tomentosenol A, a Constituent of Cerumen from the Australian Native Stingless Bee, Tetragonula carbonaria

Karina D. Hamilton, Daniel Czajkowski, Nicolas J. Kong, Trong D. Tran, Kirk R. Gustafson, Gary Pauly, Glen M. Boyle, Jacinta L. Simmons, Robert Steadman, Ryan Moseley, Peter R. Brooks, Steven M. Ogbourne, Fraser D. Russell

Summary: Bioactivity-guided fractionation was used to isolate two compounds, tomentosenol A (1) and torellianone A (2), from a cerumen extract from Tetragonula carbonaria. The anti-fibrotic activity of tomentosenol A (1) was examined using human cultured neonatal foreskin fibroblasts (NFF) and immortalised keratinocytes (HaCaTs). Tomentosenol A (1) inhibited cell proliferation and prevented scratch wound repopulation, reduced cell viability, inhibited cell differentiation, collagen production, and acted as an effective scavenger of oxidant. These findings highlight the significant anti-fibrotic potential of tomentosenol A (1) derived from cerumen.

ANTIOXIDANTS (2022)

Article Obstetrics & Gynecology

Analysis of a maternal health medicines pipeline database 2000-2021: New candidates for the prevention and treatment of fetal growth restriction

Shao Lim, Annie R. A. McDougall, Maya Goldstein, Andrew Tuttle, Roxanne Hastie, Stephen Tong, Anne Ammerdorffer, Sara Rushwan, Christina Ricci, A. Metin Gulmezoglu, Joshua P. P. Vogel

Summary: The Accelerating Innovation for Mothers project created a new database of candidate medicines for fetal growth restriction. Through a comprehensive analysis, it identified l-arginine, aspirin, and vitamin D as promising preventive agents. However, the study found that new pharmacological agents for treating fetal growth restriction are unlikely to emerge in the near future based on the current pipeline.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Article Obstetrics & Gynecology

The compatibility of oxytocin and tranexamic acid injection products when mixed for co-administration by infusion for the treatment of postpartum haemorrhage: An in vitro investigation

Pete Lambert, Alessandra Tomazzini, Philip Wright, Claire McEvoy, Ioannis D. Gallos, Anne Ammerdorffer, Lester Chinery, Arri Coomarasamy, Ahmet Metin Guelmezoglu

Summary: The compatibility of oxytocin and tranexamic acid injection products when mixed was investigated. Results showed significant interaction between certain products, leading to a reduction in oxytocin concentration. This may compromise care in emergency situations, therefore, the mixing of oxytocin and tranexamic acid injection products with intravenous fluids should be avoided until the interaction and its implications are understood.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Review Chemistry, Medicinal

Exploring Mycosporine-like Amino Acid UV-Absorbing Natural Products for a New Generation of Environmentally Friendly Sunscreens

Nedeljka Rosic, Mike Climstein, Glen M. M. Boyle, Duy Thanh Nguyen, Yunjiang Feng

Summary: Human skin needs additional protection from damaging ultraviolet radiation. Available sunscreens offer chemical protection to a certain extent, but synthetic sunscreens may not provide sufficient protection and can have negative effects on human skin and the environment. Therefore, finding photostable, biodegradable, non-toxic, and renewable natural UV filters is important. This review investigates the damaging impact of UVR on human health, the necessity of using sunscreens for UV protection, and the potential of natural UV-absorbing products.

MARINE DRUGS (2023)

Article Immunology

Bladder-draining lymph nodes support germinal center B cell responses during urinary tract infection in mice

Sophia Hawas, Dimitrios Vagenas, Ashraful Haque, Makrina Totsika

Summary: This study directly observed host adaptive immune responses in bacterial urinary tract infections (UTIs), and found that UTIs triggered increases in myeloid cells in the bladder and developed B cell immune responses in lymph nodes, which could potentially serve to control the infection.

INFECTION AND IMMUNITY (2023)

Article Oncology

Development of an in vivo murine model of perineural invasion and spread of cutaneous squamous cell carcinoma of the head and neck

Priscila O. de Lima, Natasa Broit, Johnson D. Huang, Jae H. Lim, Damien J. Gardiner, Ian S. Brown, Benedict J. Panizza, Glen M. Boyle, Fiona Simpson

Summary: Cutaneous squamous cell carcinoma of the head and neck (cSCCHN) can metastasize by invading nerves and spread toward the central nervous system. This study describes a complementary whisker pad model for investigating drivers of perineural invasion (PNI) and spread (PNS) in the head and neck environment. The results demonstrate the utility of this model for studying tumor growth and PNI, as well as its potential for use in combination with the established sciatic nerve model.

FRONTIERS IN ONCOLOGY (2023)

Article Medicine, Research & Experimental

Human IL-10-producing Th1 cells exhibit a molecular signature distinct from Tr1 cells in malaria

Chelsea L. Edwards, Susanna S. Ng, Fabian de Labastida Rivera, Dillon Corvino, Jessica A. Engel, Marcela Montes de Oca, Luzia Bukali, Teija C. M. Frame, Patrick T. Bunn, Shashi Bhushan Chauhan, Siddharth Sankar Singh, Yulin Wang, Jinrui Na, Fiona H. Amante, Jessica R. Loughland, Megan S. F. Soon, Nicola Waddell, Pamela Mukhopadhay, Lambros T. Koufariotis, Rebecca L. Johnston, Jason S. Lee, Rachel Kuns, Ping Zhang, Michelle J. Boyle, Geoffrey R. Hill, James S. McCarthy, Rajiv Kumar, Christian R. Engwerda

Summary: Control of malaria requires Th1 cells with IL-10 to mitigate inflammation, but IL-10+Tr1 cells can also promote parasite persistence or impair immunity. Molecular and phenotypic signatures distinguish IL-10-Th1 cells from IL-10+Tr1 cells in malaria-infected individuals and mice, and a conserved Tr1 cell signature is found in patients with malaria, dengue, and graft-versus-host disease.

JOURNAL OF CLINICAL INVESTIGATION (2023)

暂无数据